3min chapter

Investing With IBD cover image

Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks

Investing With IBD

CHAPTER

Dexcom's Stocks in the Diabetes Group

Dexcom is still hanging in there and fighting a, fighting a good fight. ITCI is kind of testing its 10-day moving average but it's forming an awkward looking consolidation on the weekly chart. And intracellular is another, uh, uh, non profitable biotech, but you've got triple digit revenue growth.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode